|
DNAJA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53399515312458E-11 |
| Normal-vs-Stage2 |
6.770500E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
2.41284769941785E-12 |
| Stage1-vs-Stage2 |
9.035000E-01 |
| Stage1-vs-Stage3 |
5.409200E-04 |
| Stage1-vs-Stage4 |
3.600200E-02 |
| Stage2-vs-Stage3 |
4.001600E-02 |
| Stage2-vs-Stage4 |
1.542210E-01 |
| Stage3-vs-Stage4 |
3.787800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.319180E-03 |
| Normal-vs-Asian |
1.641550E-01 |
| Caucasian-vs-AfricanAmerican |
2.846000E-01 |
| Caucasian-vs-Asian |
4.588800E-01 |
| AfricanAmerican-vs-Asian |
9.008000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.56200000045459E-07 |
| Male-vs-Female |
2.574600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.55389999978439E-07 |
| Normal-vs-Age(41-60Yrs) |
1.64313007644523E-14 |
| Normal-vs-Age(61-80Yrs) |
1.79700698765828E-12 |
| Normal-vs-Age(81-100Yrs) |
4.85900000013473E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.161210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.745600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.701650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.979000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.667000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.382800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.671580E-02 |
| Normal-vs-Grade 2 |
1.83630888273001E-12 |
| Normal-vs-Grade 3 |
1.6938672686706E-12 |
| Normal-vs-Grade 4 |
1.6983081607691E-12 |
| Grade 1-vs-Grade 2 |
2.542000E-01 |
| Grade 1-vs-Grade 3 |
2.057600E-01 |
| Grade 1-vs-Grade 4 |
2.492000E-02 |
| Grade 2-vs-Grade 3 |
4.841000E-01 |
| Grade 2-vs-Grade 4 |
3.049900E-02 |
| Grade 3-vs-Grade 4 |
1.384810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63970004241065E-09 |
| Normal-vs-ccB subtype |
1.62481139653892E-12 |
| ccA subtype-vs-ccB subtype |
3.610300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85407245112401E-14 |
| Normal-vs-N1 |
4.79519999996292E-06 |
| N0-vs-N1 |
9.590800E-01 |
|
|
